Suppr超能文献

溶酶体促渗剂给药期间的异噬功能及溶酶体内蛋白水解速率

Heterophagic function and rate of intralysosomal proteolysis during lysosomotropic agents administration.

作者信息

Korolenko T A, Pupyshev A B, Malygin A E

出版信息

Acta Biol Med Ger. 1981;40(10-11):1613-7.

PMID:7342605
Abstract

Lysosomotropic agents--Triton WR 1339 and suramin--are taken up selectively into lysosomes during in vivo administration and cause specific changes of the particles. Overloading of rat liver lysosomes by Triton WR 1339 was accompanied by the labilization of lysosomes and an increased uptake of [14C]-bovine serum albumin ([14C]-BSA) by the rat liver. The rate of intralysosomal proteolysis was not altered. The capture of 125I-labelled poly(vinylpyrrolidone) (PVP) by the liver was slightly decreased. In the case of suramin administration (250 mg/kg b.w.) the uptake of labelled protein by the liver was not changed. The increased amount of acid-insoluble radioactivity in rat liver was caused by the decrease of intralysosomal protein digestion rate. The lysosomes overloaded by the two kinds of lysosomotropic agents--Triton WR 1339 (with no changes of intralysosomal proteolysis) and suramin (with decreased rate of proteolysis) did not prevent the uptake by liver of substances captured by the adsorptive ([14C]-BSA) or fluid ([125I]-PVP) endocytosis.

摘要

溶酶体亲和剂——聚醚磺化蓖麻油(Triton WR 1339)和苏拉明——在体内给药过程中会被选择性地摄取到溶酶体中,并引起颗粒的特定变化。聚醚磺化蓖麻油(Triton WR 1339)使大鼠肝脏溶酶体超载,同时伴随着溶酶体的不稳定以及大鼠肝脏对[14C] - 牛血清白蛋白([14C] - BSA)摄取的增加。溶酶体内蛋白水解的速率没有改变。肝脏对125I标记的聚乙烯吡咯烷酮(PVP)的摄取略有减少。在给予苏拉明(250mg/kg体重)的情况下,肝脏对标记蛋白的摄取没有变化。大鼠肝脏中酸不溶性放射性的增加是由溶酶体内蛋白消化速率的降低引起的。被两种溶酶体亲和剂——聚醚磺化蓖麻油(Triton WR 1339,溶酶体内蛋白水解无变化)和苏拉明(蛋白水解速率降低)超载的溶酶体,并没有阻止肝脏对通过吸附性([14C] - BSA)或液体([125I] - PVP)内吞作用摄取的物质的摄取。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验